NCT06812572View on ClinicalTrials.gov

A Prospective Clinical Study to Evaluate the Repeatability of the Visibly Vision Test

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 4, 2019

Primary Completion Date

March 25, 2019

Study Completion Date

March 25, 2019

Conditions
MyopiaAstigmatism
Interventions
DEVICE

Visibly Vision Test

The Visibly Vision Test is used as a digital self-administered device to measure visual acuity and to subjectively measure refractive value for a patient's eye to determine the optical prescription for the conditions of myopia and astigmatism

Trial Locations (1)

78550

TRA, Harlingen

All Listed Sponsors
collaborator

ORA, Inc.

INDUSTRY

lead

Visibly

INDUSTRY

NCT06812572 - A Prospective Clinical Study to Evaluate the Repeatability of the Visibly Vision Test | Biotech Hunter | Biotech Hunter